UNDERSTANDING

the role of iron in human health and disease

IMPROVING

the diagnosis of iron disorders

DEVELOPING

better medications for common
and rare iron disorders




Latest news

Successful BioIron 2017 Conference held at UCLA

The biennial meeting of the International Bioiron Society was held at the Luskin Center at UCLA, May 7-11, 2017, organized by Elizabeta Nemeth and Tomas Ganz. It was attended by 416 participants from 30 countries, who enjoyed the program and the new conference facilities.

Allison Fisher received a Poster Award from the Society of Reproductive Investigation

At the annual conference of the Society for Reproductive Investigation, held in San Diego, March 6-10, 2018, our graduate student Allison Fisher presented her studies of the adverse interaction of iron and inflammation in a mouse model of pregnancy. Her poster attracted much attention and elicited spirited discussion by experts in the field.

Erythroferrone, discovered and characterized at the UCLA Center for Iron Disorders, undergoing commercial development

Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Silarus was founded based on intellectual property developed in our center and in-licensed from UCLA. Under a license from UCLA, Intrinsic LifeSciences has developed a "research use only" assay for human erythroferrone sold to many clinical researchers worldwide.